We aimed to evaluate treatment responses to atazanavir plus ritonavir (ATV/r) or efavirenz (EFV) in initial antiretroviral regimens among women and men, and determine if treatment outcomes differ by sex.
Pharmacology, Toxicology and Pharmaceutical Science
5
7%
Agricultural and Biological Sciences
4
5%
Biochemistry, Genetics and Molecular Biology
3
4%
Nursing and Health Professions
3
4%
Other
10
14%
Unknown
24
33%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2016.
All research outputs
#8,502,080
of 26,875,495 outputs
Outputs from Clinical Infectious Diseases
#9,514
of 17,075 outputs
Outputs of similar age
#89,042
of 320,547 outputs
Outputs of similar age from Clinical Infectious Diseases
#77
of 198 outputs
Altmetric has tracked 26,875,495 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 17,075 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.1. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,547 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 198 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.